165 related articles for article (PubMed ID: 37711052)
21. FBXW7 Enhances Cisplatin-Induced Apoptosis in Oral Cancer Cell Lines.
Yang Q; Sun Y; Qiu B; Zhao H
Int Dent J; 2023 Oct; 73(5):620-627. PubMed ID: 36481094
[TBL] [Abstract][Full Text] [Related]
22. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
[TBL] [Abstract][Full Text] [Related]
23. Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.
Yoon HE; Ahn MY; Kwon SM; Kim DJ; Lee J; Yoon JH
J Oral Pathol Med; 2016 Apr; 45(4):262-7. PubMed ID: 26332444
[TBL] [Abstract][Full Text] [Related]
24. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
[TBL] [Abstract][Full Text] [Related]
26. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
Duan Y; Huang X; Qiao B; Ma R; Li J
Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
[TBL] [Abstract][Full Text] [Related]
27. Resistance of oral squamous cell carcinoma cells to cetuximab is associated with EGFR insensitivity and enhanced stem cell-like potency.
Ohnishi Y; Minamino Y; Kakudo K; Nozaki M
Oncol Rep; 2014 Aug; 32(2):780-6. PubMed ID: 24926885
[TBL] [Abstract][Full Text] [Related]
28. Licochalcone D directly targets JAK2 to induced apoptosis in human oral squamous cell carcinoma.
Seo JH; Choi HW; Oh HN; Lee MH; Kim E; Yoon G; Cho SS; Park SM; Cho YS; Chae JI; Shim JH
J Cell Physiol; 2019 Feb; 234(2):1780-1793. PubMed ID: 30070696
[TBL] [Abstract][Full Text] [Related]
29. Suprabasin enhances the invasion, migration, and angiogenic ability of oral squamous cell carcinoma cells under hypoxic conditions.
Houri A; Mukudai Y; Abe Y; Watanabe M; Nara M; Miyamoto S; Kurihara M; Shimane T; Shirota T
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896786
[TBL] [Abstract][Full Text] [Related]
30. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma.
Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY
Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765
[TBL] [Abstract][Full Text] [Related]
31. Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells.
Liu JF; Chang TM; Chen PH; Lin JS; Tsai YJ; Wu HM; Lee CJ
J Food Biochem; 2022 Nov; 46(11):e14221. PubMed ID: 35596593
[TBL] [Abstract][Full Text] [Related]
32. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
[TBL] [Abstract][Full Text] [Related]
33. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
Yang M; Luo Q; Chen X; Chen F
J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
[TBL] [Abstract][Full Text] [Related]
34. Nitidine chloride represses Mcl-1 protein via lysosomal degradation in oral squamous cell carcinoma.
Yang IH; Jung W; Kim LH; Shin JA; Cho NP; Hong SD; Hong KO; Cho SD
J Oral Pathol Med; 2018 Oct; 47(9):823-829. PubMed ID: 29924888
[TBL] [Abstract][Full Text] [Related]
35. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition.
Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y
PeerJ; 2022; 10():e12991. PubMed ID: 35223210
[TBL] [Abstract][Full Text] [Related]
36. Quercetin Induces Cell Cycle Arrest and Apoptosis in YD10B and YD38 Oral Squamous Cell Carcinoma Cells.
Son HK; Kim D
Asian Pac J Cancer Prev; 2023 Jan; 24(1):283-289. PubMed ID: 36708578
[TBL] [Abstract][Full Text] [Related]
37. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
Lu X; Wang Z; Huang H; Wang H
J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
[TBL] [Abstract][Full Text] [Related]
38. Anticancer effects of gossypetin from Hibiscus sabdariffa in oral squamous cell carcinoma.
Huang K; Liu Z; Kim MO; Kim KR
J Appl Oral Sci; 2023; 31():e20230243. PubMed ID: 37820185
[TBL] [Abstract][Full Text] [Related]
39. Oridonin induces the apoptosis of mucoepidermoid carcinoma cell lines in a myeloid cell leukemia‑1‑dependent manner.
Han JM; Hong KO; Yang IH; Ahn CH; Jin B; Lee W; Jung YC; Kim KA; Shin JA; Cho SD; Hong SD
Int J Oncol; 2020 Jul; 57(1):377-385. PubMed ID: 32467983
[TBL] [Abstract][Full Text] [Related]
40. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
